Clinical Trial Update: Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Nd-YAG laser versus epidermal growth factor for myogenic temporomandibular disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorders

Drugs mentioned

• Epidermal Growth Factor (epidermal growth factor)
• Nd-YAG laser (neodymium-doped yttrium aluminum garnet laser)

Snippet

Sponsor: Alexandria University | Conditions: Temporomandibular Joint Disorders | Phase 4 | Status: COMPLETED